Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update in the Therapy of Advanced Neuroendocrine Tumors
Inbal Uri, Shani Avniel-Polak, David J. Gross, et al.
Current Treatment Options in Oncology (2017) Vol. 18, Iss. 12
Closed Access | Times Cited: 20

Showing 20 citing articles:

Current best practice in the management of neuroendocrine tumors
Marina Tsoli, Eleftherios Chatzellis, Anna Koumarianou, et al.
Therapeutic Advances in Endocrinology and Metabolism (2018) Vol. 10
Open Access | Times Cited: 62
The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition
Jakub Pobłocki, Anna Jasińska, Anhelli Syrenicz, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1437-1437
Open Access | Times Cited: 38
Last decade of advances in gastric neuroendocrine tumors: Innovations, challenges, and future directions
Grigorios Christodoulidis, Marina Nektaria Kouliou, Dimitrios Ragias, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 5
Closed Access
Multiple modes of cell death in neuroendocrine tumors induced by artesunate
Ge Yan, Mona Dawood, Madeleine Böckers, et al.
Phytomedicine (2020) Vol. 79, pp. 153332-153332
Closed Access | Times Cited: 22
Octreotide-Conjugated Core-Cross-Linked Micelles with pH/Redox Responsivity Loaded with Etoposide for Neuroendocrine Neoplasms Therapy and Bioimaging with Photoquenching Resistance
Jian’an Bai, Ye Tian, Fangzhou Liu, et al.
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 20, pp. 18111-18122
Closed Access | Times Cited: 20
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
Lingaku Lee, Irene Ramos-Álvarez, Robert T. Jensen
Cancers (2022) Vol. 14, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 11
Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort study
Michala Danielle Zacho, Peter Iversen, Gerda Elisabeth Villadsen, et al.
Scandinavian Journal of Gastroenterology (2021) Vol. 56, Iss. 3, pp. 289-297
Open Access | Times Cited: 13
Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms—A Preliminary Study
Barbara Bober, Marek Saracyn, Kornelia Zaręba, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 919-919
Open Access | Times Cited: 10
Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors
Mengxia Li, Qiyong Li, Min Xiao, et al.
Hepatobiliary & pancreatic diseases international (2019) Vol. 18, Iss. 6, pp. 538-545
Closed Access | Times Cited: 13
Primary hepatic neuroendocrine carcinoma coexisting with distal cholangiocarcinoma
Qi Xin, Rong Lv, Cheng Lou, et al.
Medicine (2020) Vol. 99, Iss. 26, pp. e20854-e20854
Open Access | Times Cited: 9
What have we learnt from the past – would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
Rahel Stiefel, Kuno Lehmann, Thomas Winder, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
Giulia Bresciani, Angeliki Ditsiou, Chiara Cilibrasi, et al.
Endocrine Connections (2019) Vol. 8, Iss. 6, pp. 680-690
Open Access | Times Cited: 7
Design, synthesis and biological evaluation of novel pyrazole derivatives bearing sulfonamide scaffold as antiproliferative agents
Burçin Vurucu, Samet Mert, Serkan Koldaş, et al.
Journal of the Iranian Chemical Society (2023) Vol. 20, Iss. 5, pp. 1107-1118
Closed Access | Times Cited: 2
Capecitabine plus temozolomide in well- or moderately-differentiated primary atypical neuroendocrine tumours — single-centre experience of two cases
Anna La Salvia, Maria Pia Brizzi, Leonardo Muratori, et al.
Endokrynologia Polska (2019) Vol. 70, Iss. 4, pp. 380-383
Open Access | Times Cited: 5
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms
Ilena Boemi, Sara Piccini, Federico Colombo, et al.
Endocrine (2023) Vol. 83, Iss. 3, pp. 810-823
Closed Access | Times Cited: 1
Cutaneous Metastasis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets).
Rohit Dhingra, Julie Y. Tse, Muhammad Wasif Saif
PubMed (2018) Vol. 19, Iss. 5
Closed Access | Times Cited: 2
Double contrast-enhanced ultrasonography of a small intestinal neuroendocrine tumor: a case report of a recommendable imaging modality
Jie‐Ying Zhao, Hua Zhuang, Yuan Luo, et al.
Precision Clinical Medicine (2020) Vol. 3, Iss. 2, pp. 147-152
Open Access | Times Cited: 2
Advances in Diagnosis and Treatment of Primary Hepatic Neuroendocrine Neoplasms
梦霞 李
Advances in Clinical Medicine (2019) Vol. 09, Iss. 03, pp. 225-234
Closed Access
Clinical Efficacy of First and Second Series of Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Neoplasm: A Cohort Study
Michala Danielle Zacho, Patrick Sønderskov Iversen, Gerda Elisabeth Villadsen, et al.
Research Square (Research Square) (2020)
Open Access
What we have learnt from the past – would treament decicions for GEP- NET patients differ between 2012 to 2016 by the new recommendations in 2022?
Rahel Stiefel, Kuno Lehmann, Thomas Winder, et al.
Research Square (Research Square) (2022)
Open Access
Systemic Treatments and Related Side Effects in Neuroendocrine Tumors
Seher Nazlı Kazaz, İlhan Öztop
Springer eBooks (2022), pp. 187-195
Closed Access
Page 1

Scroll to top